Search
for
Sort by
Research 421–450 of 438
- Manifestasi Klinis COVID-19 Pada Kulit
- Gray Patch Tinea Capitis Caused by Microsporum canis
- Diagnosis dan Tata Laksana Post-Traumatic Stress Disorder
- Diagnosis dan Farmakoterapi Penyakit Paru Obstruktif Kronis
- Tata Laksana Onikomikosis Candida
- Tata Laksana Gangguan Kognitif di Layanan Primer
- Resistensi Antibiotik pada Infeksi Saluran Kemih Anak
- Hipoalbuminemia: Patofisiologi dan Tata Laksana
- Human Metapneumovirus (HMPV): Gambaran Klinis dan Tata Laksana
- Deteksi Dini dan Pencegahan Risiko Bunuh Diri pada Remaja
- Leukokoria sebagai Tanda Peringatan Penyakit Coats dan Gangguan Retina Lainnya
- Pendekatan Diagnosis Ensefalomielitis Diseminata Akut
- Diagnosis dan Tata Laksana Frambusia
- Sindrom Fahr: Kalsifikasi Intraserebral Patologis
- Tinea Kapitis pada Dua Saudara Kandung
- Peran Vitamin D dalam Kesehatan Kulit
- Wnt/β-Catenin Signaling Pathway Targeting Androgenetic Alopecia: How Far Can We Go Beyond Minoxidil and Finasteride?
- Skin Care Properties of Grape Seed Polyphenols, a By-Product of the Winery Industry
- Alopecia induced by CDK 4/6 Inhibitors and its Impact on the Quality of Life of Patients with advanced Breast cancer
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients.
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Impact of CDK4/6 inhibitors on health-related quality of life outcomes in patients with metastatic breast cancer: A systematic review and meta-analysis
- Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China
- Safety and patient-reported outcomes in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated with CDK4/6 inhibitors in China: A cross-sectional study.
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in patients with breast cancer.
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane‐induced alopecia
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study